Position in ALT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,943,884
-$1,277,566 QoQ
Shares Held
639,436
-38.9% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 210 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 83%
Shared 8%
None 9%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ALT ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ALT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,943,884 | 639,436 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,221,450 | 1,045,926 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,024,166 | 283,703 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,122,662 | 297,789 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,731,706 | 447,470 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,462,345 | 492,469 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,567,107 | 633,441 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,968,753 | 646,377 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,791,656 | 570,174 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,389,550 | 234,730 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,942,076 | 261,518 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $492,051 | 189,251 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $904,575 | 256,254 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,390,632 | 566,501 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,925,878 | 177,865 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,226,743 | 174,373 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,443,358 | 123,364 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $442,755 | 72,702 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $718,785 | 78,470 | Shares | Defined | 2022-02-09 | |
| 2020-09-30 | $638,246 | 48,352 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $517,849 | 48,352 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $155,209 | 48,352 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||